TFPP for Post-Traumatic Stress Disorder

VA New York Harbor Healthcare System - Manhattan Campus, New York, NY
Post-Traumatic Stress DisorderTFPP - Other
18 - 70
All Sexes
What conditions do you have?

Study Summary

This trial is testing a new type of therapy, Trauma-Focused Psychodynamic Psychotherapy (TFPP), to see if it helps Veterans with PTSD who have not responded to standard treatment.

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

1 Primary · 9 Secondary · Reporting Duration: baseline, 16 weeks (termination), 3 month follow-up

Assessment of life events on LEC.
Wounds and Injuries
Month 3
Change in PTSD symptoms as per DSM-5 as measured by CAPS-5
Change in adult separation anxiety symptoms as measured by the SCI-SAS
Change in anxiety symptoms as measured by HARS.
Change in degree of limitation in ability to work as measured by WLQ
Mental Depression
Change in mental and physical symptoms as measured by VR-12.
Change in reflective capacity as measured by RF score.
Change in work and social adjustment as measured by WSAS.

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

1 of 2
1 of 2

Active Control

Experimental Treatment

75 Total Participants · 2 Treatment Groups

Primary Treatment: TFPP · No Placebo Group · N/A

Experimental Group · 1 Intervention: TFPP · Intervention Types: Other
ActiveComparator Group · 1 Intervention: TAU · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 16 weeks (termination), 3 month follow-up

Who is running the clinical trial?

International Psychoanalytic AssociationUNKNOWN
VA New York Harbor Healthcare SystemFED
23 Previous Clinical Trials
17,390 Total Patients Enrolled
American Psychoanalytic Association Fund for Psychoanalytic ResearchUNKNOWN
Weill Medical College of Cornell UniversityLead Sponsor
1,007 Previous Clinical Trials
1,330,878 Total Patients Enrolled
Barbara Milrod, MDPrincipal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
201 Total Patients Enrolled

Eligibility Criteria

Age 18 - 70 · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Is participation in this trial open to geriatric individuals?

"The eligibility criteria for this trial requires that participants are no older than 70 and not younger than 18." - Anonymous Online Contributor

Unverified Answer

How many participants are being included in this investigation?

"Affirmative. According to information posted on, recruitment for this trial is currently underway and began on November 2nd 2018 with an update occurring five years later in November of 2022. A total of 75 patients need to be enrolled from one location." - Anonymous Online Contributor

Unverified Answer

Who meets the criteria to take part in this medical experiment?

"To take part in this trial, patients must be aged 18 to 70 and have a confirmed diagnosis of PTSD with a CAPS score over 40. Additionally, they must remain stable on their psychiatric medications for two months prior to enrolling as well as having previously declined or dropped out of treatment options." - Anonymous Online Contributor

Unverified Answer

Is this medical experiment actively seeking volunteers?

"Affirmative. The information posted on suggests that this medical trial is open for recruitment, with its initial posting dated November 2nd 2018 and last update taking place on the 7th of November 2022. 75 individuals are needed from a single site to participate in the study." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.